CDK9 INHIBITORS: a promising combination partner in the treatment of hematological malignancies

Home   |   Publication   |   CDK9 INHIBITORS: a promising combination partner in the treatment of hematological malignancies
Publications
75 +
Clinical Trials Ran
0 +
Approved Therapies
0

Areas of Expertise